EFDID: 164557EFD: View Filing

Issuer: DelMar Pharmaceuticals, Inc. (0001498382) - D

Accession: 0001013762-16-001563 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001498382
  • Entity Name:
    DelMar Pharmaceuticals, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    NEVADA
  • Year of Inc:
    Over 5 years ago
  • Address:
    SUITE 720-999 WEST BROADWAY
    VANCOUVER, A1 V5Z 1K5
  • Persons:
    Related Persons 7
    Jeffrey Bacha
    Executive Officer, Director
    Dennis Brown
    Executive Officer, Director 
    Officer/Director
    Scott Praill
    Executive Officer 
    Officer
    Lynda Cranston
    Director
    John K Bell
    Director
    Erich Mohr
    Director
    Robert Toth
    Director
EDGAR: Offering Information
  • Accession Date:
    05/10/2016
  • First Sale Date:
    04/29/2016
  • Offering Amount:
    Indefinite
  • Amount Sold:
    $5,600,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:AL, CA, IA, IN, KS, MN, NJ, OK, PA, TN, TX, WI
Inactive:GA, IL, OH, PR, WA
EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Newport Coast Scurities Inc 16944 None None CA, FL, GA, KS, MA, NJ, NY, OK, PA, TX, WI
Aegis Capital Corp 15007 None None CA, FL, GA, IN, NJ, NY, OH, WA
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
DelMar Pharmaceuticals, Inc./s/ Jeffrey BachaJeffrey BachaCEO2016-05-10